MariMed Inc. (CSE: MRMD)
Canada
· Delayed Price · Currency is CAD 0.140
-0.010 (-6.67%)
Dec 19, 2024, 4:00 PM EST
MariMed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 157.86 | 148.6 | 134.01 | 121.46 | 50.9 | 45.6 | Upgrade
|
| Revenue Growth (YoY) | 8.47% | 10.89% | 10.33% | 138.66% | 11.60% | 284.79% | Upgrade
|
| Cost of Revenue | 90.39 | 82.68 | 70.05 | 55.2 | 19.57 | 26.9 | Upgrade
|
| Gross Profit | 67.48 | 65.92 | 63.96 | 66.26 | 31.32 | 18.7 | Upgrade
|
| Selling, General & Admin | 59.78 | 50.72 | 38.88 | 37.54 | 15.81 | 13.03 | Upgrade
|
| Operating Expenses | 59.9 | 50.84 | 42.63 | 39.4 | 16.79 | 46.37 | Upgrade
|
| Operating Income | 7.58 | 15.08 | 21.33 | 26.86 | 14.53 | -27.67 | Upgrade
|
| Interest Expense | -6.62 | -9.19 | -1.69 | -2.36 | -9.81 | -12.72 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.27 | 0.96 | 0.11 | 0.26 | 0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.77 | -0.65 | -0.05 | -0 | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | 0.3 | 5.51 | 20.55 | 24.61 | 4.98 | -39.92 | Upgrade
|
| Merger & Restructuring Charges | -0.85 | -0.7 | -0.96 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -2.66 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.08 | -0.08 | -0.08 | -0.8 | -0.35 | -30.98 | Upgrade
|
| Asset Writedown | -0.91 | -0.91 | - | - | -0.08 | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | -8.25 | Upgrade
|
| Other Unusual Items | -9.73 | -10.43 | - | - | -0.04 | -0.01 | Upgrade
|
| Pretax Income | -10.35 | -6.6 | 19.51 | 23.82 | 4.5 | -81.81 | Upgrade
|
| Income Tax Expense | 3.72 | 9.41 | 5.89 | 16.19 | 2.07 | 0.07 | Upgrade
|
| Earnings From Continuing Operations | -14.07 | -16.01 | 13.61 | 7.62 | 2.43 | -81.88 | Upgrade
|
| Minority Interest in Earnings | -0.06 | -0.02 | -0.15 | -0.4 | -0.29 | 0.7 | Upgrade
|
| Net Income | -14.13 | -16.03 | 13.47 | 7.23 | 2.14 | -81.18 | Upgrade
|
| Net Income to Common | -14.13 | -16.03 | 13.47 | 7.23 | 2.14 | -81.18 | Upgrade
|
| Net Income Growth | - | - | 86.41% | 236.99% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 378 | 363 | 338 | 326 | 267 | 209 | Upgrade
|
| Shares Outstanding (Diluted) | 378 | 363 | 380 | 372 | 324 | 209 | Upgrade
|
| Shares Change (YoY) | 6.67% | -4.44% | 2.12% | 14.88% | 55.31% | 8.50% | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | 0.04 | 0.02 | 0.01 | -0.39 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | 0.04 | 0.02 | 0.01 | -0.39 | Upgrade
|
| EPS Growth | - | - | 99.40% | 149.07% | - | - | Upgrade
|
| Free Cash Flow | -5.85 | -12.22 | -4.83 | 17.98 | -1.31 | -33.81 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.01 | 0.05 | -0.00 | -0.16 | Upgrade
|
| Gross Margin | 42.74% | 44.36% | 47.73% | 54.55% | 61.55% | 41.01% | Upgrade
|
| Operating Margin | 4.80% | 10.15% | 15.92% | 22.12% | 28.55% | -60.67% | Upgrade
|
| Profit Margin | -8.95% | -10.79% | 10.05% | 5.95% | 4.21% | -178.02% | Upgrade
|
| Free Cash Flow Margin | -3.71% | -8.22% | -3.60% | 14.80% | -2.57% | -74.13% | Upgrade
|
| EBITDA | 17.95 | 23.65 | 26.04 | 29.65 | 16.71 | -26.47 | Upgrade
|
| EBITDA Margin | 11.37% | 15.92% | 19.43% | 24.41% | 32.84% | -58.05% | Upgrade
|
| D&A For EBITDA | 10.37 | 8.57 | 4.71 | 2.79 | 2.18 | 1.2 | Upgrade
|
| EBIT | 7.58 | 15.08 | 21.33 | 26.86 | 14.53 | -27.67 | Upgrade
|
| EBIT Margin | 4.80% | 10.15% | 15.92% | 22.12% | 28.55% | -60.67% | Upgrade
|
| Effective Tax Rate | - | - | 30.21% | 67.99% | 45.97% | - | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 45.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.